Skip to main content

Psoriasis- Mediation of Skin Phenotype by Circulatory Pathogenic T Lymphocytes

  • Chapter
Strategies for Immunointerventions in Dermatology
  • 81 Accesses

Abstract

Psoriasis is one of the most common skin diseases present throughout the worldwide population affecting about 2% of individuals [1]. It has several different clinical appearances, but the most common phenotype consists of symmetrically distributed, persistent erythematous scaling plaques.Within these cutaneous lesions, there is infiltration of inflammatory cells, prominent keratinocyte hyperplasia with altered differentiation, neovascularization of the dermis,and activation of immunocompetent cells-T cells and dendritic antigen-presenting cells [2]. One of the most difficult problems for investigators studying this disease is to be able to determine with certainty which cellular and molecular events are of primary importance and which changes are secondary. The confederacy of cell types participating in this disorder, together with the panoply of cytokines and the rapidity of evolution and disappearance of skin lesions, has confounded even the most astute clinicians and bench researchers for the past century. Perhaps the greatest obstacle has been the lack of an appropriate and relevant animal model that recapitulates all of the important and characteristic cutaneous changes present in human psoriatic plaques.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Krueger GG, Bergstresser PR, Lowe NJ, Voorhees JJ, Weinstein GD (1984) Psoriasis. J Am Acad Dermatol 11:937–947.

    Article  PubMed  CAS  Google Scholar 

  2. Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127:871–884.

    Article  PubMed  CAS  Google Scholar 

  3. Farber E, Nail ML, Strefling A (1985) Psoriasis: a disease of the total skin. J Am Acad Dermatol 12:150–156.

    Article  PubMed  CAS  Google Scholar 

  4. Christophers E, Mrowietz U (1995) The inflammatory infiltrate in psoriasis. Clin Dermatol 13:131–135.

    Article  PubMed  CAS  Google Scholar 

  5. Valdimarsson H, Baker BS, Jonsdottir I, Fry L. (1986) Psoriasis: a disease of abnormal keratinocyte proliferation induced by T lymphocytes. Immunol Today 7:256–259.

    Article  Google Scholar 

  6. Gottlieb AB(1988) Immunologic mechanisms in psoriasis.J Am Acad Dermatol 18:1376–1380

    Article  PubMed  CAS  Google Scholar 

  7. Baadsgaard O, Fisher GJ, Voorhees JJ, Cooper KD (1990) The role of the immune system in the pathogenesis of psoriasis. J Invest Dermatol 95:32s–34s.

    Article  Google Scholar 

  8. Nickoloff BJ, Mitra RS, Green J, Zheng XG, Shimizu Y, Thompson C, Turka LA (1993) Accessory cell function of keratinocytes for superantigens: dependence on lymphocyte function-associated antigen-1 /intercellular adhesion molecule 1 interaction. J Immunol 150:2148–2159.

    PubMed  CAS  Google Scholar 

  9. Nestle F,Turka LA,Nickoloff BJ(1994)Characterization of dermal dendritic cells in psoriasis: autostimulation of T lymphocytes and induction of Thl type cytokines.J Clin Invest 94:202–209

    Article  PubMed  CAS  Google Scholar 

  10. Russell TJ, Schultes LM, Kuban DJ (1972) Histocompatibility (HL-A) antigens associated with psoriasis. N Engl J Med 287:738–740.

    Article  PubMed  CAS  Google Scholar 

  11. White SH., Newcomer VD, Mickey MR, Terasaki PI (1972) Disturbance of HL-A antigen frequency in psoriasis. N Engl I Med 287:740–743.

    Article  CAS  Google Scholar 

  12. Henseler T, Christophers E (1985) Psoriasis of early and late onset: charac terization of two types of psoriasis vulgaris. J Am Acad Dermatol 1 3:450–456.

    Article  Google Scholar 

  13. Van Scott R, Auerbach, Weinstein GD (1964) Parenteral methotrexate in psoriasis. Arch Dermatol 89:550–556.

    Article  Google Scholar 

  14. Mueller W, Herrmann B (1979) Cyclosporin A for psoriasis, N Engl J Med 301:555.

    PubMed  CAS  Google Scholar 

  15. Krueger GG, Manning DD, Malouf j, Ogden B (1975) Long-term maintenance of psoriatic human skin on congenitally athymic (nude) mice. I Invest Dermatol 64:307–312.

    Article  CAS  Google Scholar 

  16. Haftek M, Ortonne JP, Staquet MJ, Viae J, Thivolet J (1981) Normal and psoriatic human skin grafts on “nude” mice: morphological and immunochemical studies. J Invest Dermatol 76:48–52

    Article  PubMed  CAS  Google Scholar 

  17. Fraki JE, Briggaman RA, Lazarus GS (1982) Umnvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice. Science 215:685–687.

    Article  PubMed  CAS  Google Scholar 

  18. Burg G, Braun-Falco O (1970) Das entzündliche Infiltrat bei Psoriasis vulgaris. Arch Clin Exp Dermatol 236:297–314.

    Article  Google Scholar 

  19. Baker BS, Swain AF, Valdimarsson H, Fry L (1984) I cell subpopulations in the blood and skin of patients with psoriasis. Br J Dermatol 110:37–44.

    Article  PubMed  CAS  Google Scholar 

  20. Onuma S (1994) Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J Dermatol 21:223–232.

    PubMed  CAS  Google Scholar 

  21. Krueger JG, Krane JF, Carter ML), Gottlieb AB (1990) Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94:135S–140S.

    Article  PubMed  CAS  Google Scholar 

  22. Prens ER, Debets, Hegmans 1 (1995) T lymphocytes in psoriasis. Clin Dermatol 13:115–129.

    Article  PubMed  CAS  Google Scholar 

  23. Marguerie CC, Lunardi C So A (1992) PCR-based analysis of the ICR repertoire in human autoimmune diseases. Immunol Today 13:336–338.

    Article  PubMed  CAS  Google Scholar 

  24. Dunn DA, Gadenne AS, Simha S, Lerner EA, Bigby M, Bleicher PA (1993) T-cetl receptor V beta expression in normal human skin. Proc Natl Acad Sei USA 90:1267–1271.

    Article  CAS  Google Scholar 

  25. Lewis HM, Baker BS, Bokth S, Powles AJ, Garioch J J, Valdimarsson, Fry I (1993) Restricted T-cell receptor V beta gene usage m the skin oi patients with guttäte and chronic plaque psoriasis. Br J Dermatol 129:514–520.

    Article  PubMed  CAS  Google Scholar 

  26. Menssen A, Trommler P, Vollmer S, Schendel D, Albert E, Gurtler L, Riethrnuller G, Prinz JC (1995) Evidence for an antigen specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 1 55:4078–4083.

    Google Scholar 

  27. Boehncke WH., Kuenzlen C, Zollner TM, Mielke V, Sterry W (1994) Predominant usage of distinct T-cell receptor V beta regions by epiderinotropic T cells in psoriasis. Exp Dermatol 3:161–163.

    Article  PubMed  CAS  Google Scholar 

  28. Chang JC, Smith LR, Froning KJ, Schwabe BJ, Laxer JA, Ca rail i LL, Kurland HH, Karasek MA, Wilkinson DI, Brustoff SW (1994) CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. Proc Natl Acad Sei USA 91:9282–9286.

    Article  CAS  Google Scholar 

  29. Leung DY, Travers JB, Giorno R, Norris DA, Skinner R, Aelion J, Kazemi LV, Kim MH, Trumble AE, Kotb M, Schlievert PM (1995) Evidence for a streptococcal superantigen-driven process in acute guttäte psoriasis. J Clin Invest 96:2106–2112.

    Article  PubMed  CAS  Google Scholar 

  30. Wyyte JH, Baughman RI) (1964) Acute guttäte psoriasis and streptococcal infection. Arch Dermatol 89:350–356.

    Article  Google Scholar 

  31. Kotzin BL, Leung DY, Kappler J, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immunol 54:99–166.

    Article  PubMed  CAS  Google Scholar 

  32. Nickoloff BJ, Mitra RS, Green J, Shimizu Y, Thompson C, Turka LA (1993) Activated kerati- nocytes present bacterial-derived superantigens to T lymphocytes: relevance to psoriasis. J Derm Sei 6:127–133.

    Article  CAS  Google Scholar 

  33. Leung DY, Walsh P, Giorno R, Norris DA (1993) A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol 100:225–228.

    Article  PubMed  CAS  Google Scholar 

  34. Boehncke WJ, Dressel D, Manfras B, Zollner TM, Wettstein A, Böhm OB, Sterry W (1995) T-cell-receptor repertoire in chronic plaque-stage psoriasis is restricted and lacks enrichment of superantigen-associated V beta regions. J Invest Dermatol 104:725–728.

    Article  PubMed  CAS  Google Scholar 

  35. Weinshenker BG, Bass BH, Ebers GC, Rice GP (1989) Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment. J Am Acad Dermatol 20:1132–1133.

    Article  PubMed  CAS  Google Scholar 

  36. Morel P, Revillard JP, Nicolas JF, Wijdenes J, Rizova H, Thivolet J (1992) Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmun 5:465–477.

    Article  PubMed  CAS  Google Scholar 

  37. Rizova H, Nicolas JF, Morel P, Kanitakis J, Demidem A, Revillard JP, Wijdenes J, Thivolet J, Schmitt S (1994) The effect of anti-CD4 monoclonal antibody treatment on immunopatho- logical changes in psoriatic skin. J Derm Sei 7:1–13.

    Article  CAS  Google Scholar 

  38. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG (1996) Response of psoriasis to a lymphocyte-selective toxin (DAB-IL-2) suggest a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1:442–447.

    Article  Google Scholar 

  39. Sundberg JP, Beamer WG, Shultz LD, Dunstan DW (1990) Inherited mouse mutations as models of human adnexal, cornification, and papulosquamous dermatoses. J Invest Dermatol 95:62S–63S.

    Article  Google Scholar 

  40. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ (1990) Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315–1327.

    Article  PubMed  CAS  Google Scholar 

  41. Breban M, Hammer RE, Richardson JA, Taurog JD (1993) Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 178:1607–1616.

    Article  PubMed  CAS  Google Scholar 

  42. Sundberg JP, Boggess D, Sundberg BA, Beamer WG, Shultz LD (1993) Epidermal dendritic cell populations in the flaky skin mutant mouse. Immunol Invest 22:389–401.

    Article  PubMed  CAS  Google Scholar 

  43. Boehncke WH., Sterry W, Hainzl A, Scheffold W, Kaufmann R (1994) Psoriasiform architecture of murine epidermis overlying human psoriatic dermis transplanted onto SCID mice. Arch Dermatol Res 286:325–330.

    Article  PubMed  CAS  Google Scholar 

  44. Carroll JM, Romero MR, Watt FM (1995) Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83:957–968.

    Article  PubMed  CAS  Google Scholar 

  45. Bullard DC, Scharffetter-Kocharek K, McArthur MJ, Chosay JG, McBride MA, Montgomery CM, Beaudet AL (1996) A polygenic mouse model of psoriasiform skin disease in CD18-de- ficient mice. Proc Natl Acad Sei USA 93:2116–2121.

    Article  CAS  Google Scholar 

  46. Robles AJ, Larcher F, Whalin RB, Murillas R, Richie E, Gimenez-Conti IB, Jorcano JL, Conti (1996) Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sei USA 93:7634–7638.

    Article  CAS  Google Scholar 

  47. Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt H, Chen CH, Rosen CA, Stewart CL (1996) iKBß deficiency results in a sustained NF-KB response and severe widespread dermatitis in mice. Mol Cell Biol 16:2341–2349.

    PubMed  CAS  Google Scholar 

  48. Montagna W (1971) Cutaneous comparative biology. Arch Dermatol 104:577–591.

    Article  PubMed  CAS  Google Scholar 

  49. Nickoloff BJ, Kunkel SL, Burdick M, Strieter RM (1995) Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model. Am J Pathol 146:580–588.

    CAS  Google Scholar 

  50. Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Saint Andre JP, Verret JL (1990) Psoriasis after allogeneic bone marrow transplantation. Arch Dermatol 126:1523.

    Article  PubMed  CAS  Google Scholar 

  51. Eedy DJ, Burrows D, Bridges JM, Jones FG (1990) Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 300:908.

    Article  PubMed  CAS  Google Scholar 

  52. Jowitt SN, Yin JA (1990) Psoriasis and bone marrow transplantation. BMJ 300:1398–1399.

    Article  PubMed  CAS  Google Scholar 

  53. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878–1887.

    Article  PubMed  CAS  Google Scholar 

  54. Jeffes EW, Lee GC, Said S, Sabahi M, McCullough JL, Herrod R, Alzona CP, Linden KG, Soundararajan D, Edwards S et al. (1995) Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity.J Invest Dermatol 105:733–738

    Article  PubMed  Google Scholar 

  55. Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in psoriasis is characterized by a T helper type 1 cell mediated response. I Invest Dermatol 101:701–705.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nickoloff, B.J. (1997). Psoriasis- Mediation of Skin Phenotype by Circulatory Pathogenic T Lymphocytes. In: Burg, G., Dummer, R.G. (eds) Strategies for Immunointerventions in Dermatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60752-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60752-3_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64539-6

  • Online ISBN: 978-3-642-60752-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics